Company: KMRK
Filing Date: 2025-03-25
Form Type: DRS/A
Source: 0001013762-25-001825
Chunk: 164

Company: K-TECH SOLUTIONS CO LTD
Filing Date: 2025-03-25
Form: DRS/A
Chunk 164
---
 |     | Number of 
 shares    |
| [Revere Securities LLC] |     |           |
| Total                   |     |           |

The underwriters are offering the Shares subject to its acceptance of the Shares from us and subject to prior sale. The Underwriting Agreement provides that the obligations of the underwriters to pay for and accept delivery of the Shares offered by this prospectus are subject to the approval of certain legal matters by their counsel and to certain other conditions. The underwriters are obligated to take and pay for all of the Shares offered by this prospectus if any such shares are taken. We agree to indemnify the underwriters and certain of their controlling persons against certain liabilities, including liabilities under the Securities Act, and to contribute to payments that the underwriters may be required to make in respect of those liabilities. Over-Allotment Option We agree to grant to the underwriters an option, exercisable for 45 days from the closing of this offering, to purchase up to 15% additional Ordinary Shares at the IPO price listed on the cover page of this prospectus, less underwriting discounts. The underwriters may exercise this option solely for the purpose of covering over -allotments, if any, made in connection with the offering contemplated by this prospectus. To the extent the option is exercised, each underwriter will become obligated, subject to certain conditions, to purchase about the same percentage of the additional Ordinary Shares as the number listed next to the underwriters’ name in the preceding table. Representative’s Warrants In connection with and upon closing of the Offering, the Company shall grant warrants equal to five percent (5.0%) of the total number of Shares issued in the Offering (the “Warrants”); provided that the Warrants shall be exercisable at a strike price equal to one hundred and twenty percent (120.0%) of the Offering price offered to the public, for nominal consideration. Any and all Warrants to be issued to REVERE will be due and payable upon the closing of the IPO and shall be issued to REVERE in conjunction with the closing of the IPO (unless otherwise agreed to in writing). The Warrants shall not be sold during the Offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of the commencement of sales of the